Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases
出版年份 2020 全文链接
标题
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases
作者
关键词
-
出版物
CURRENT MICROBIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-30
DOI
10.1007/s00284-020-02053-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers
- (2019) Ciaran Patrick Kelly et al. Frontiers in Microbiology
- The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on Blastocystis ST3
- (2019) M. Lepczyńska et al. Gut Pathogens
- Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial
- (2019) Hassan Seddik et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections
- (2019) Dorota Czerucka et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model
- (2019) F. Briand et al. Beneficial Microbes
- Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mouse
- (2019) Jin-Pei Dong et al. CHINESE MEDICAL JOURNAL
- The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial
- (2019) Dawood Aghamohammadi et al. Trials
- Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardii
- (2019) Benjamin Offei et al. GENOME RESEARCH
- Lactulose: Patient- and dose-dependent prebiotic properties in humans
- (2019) Jakub Ruszkowski et al. ANAEROBE
- Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study
- (2018) Jeppe West Carstensen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Probiotic strains detect and suppress cholera in mice
- (2018) Ning Mao et al. Science Translational Medicine
- Biofilms and their properties
- (2018) Håkon Valen et al. EUROPEAN JOURNAL OF ORAL SCIENCES
- Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: A systematic review and meta-analysis
- (2018) Lynne V. McFarland et al. Travel Medicine and Infectious Disease
- The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards?
- (2018) Michele Di Stefano et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Saccharomyces boulardii CNCM I-745 Restores intestinal Barrier Integrity by Regulation of E-cadherin Recycling
- (2017) Chloé Terciolo et al. Journal of Crohns & Colitis
- Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?
- (2017) C. Neut et al. MEDECINE ET MALADIES INFECTIEUSES
- Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
- (2017) Glenn R. Gibson et al. Nature Reviews Gastroenterology & Hepatology
- Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
- (2017) Paola Brun et al. PLoS One
- Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer
- (2017) Giuseppe L. Banna et al. Frontiers in Pharmacology
- Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
- (2017) Beata Sulik-Tyszka et al. Probiotics and Antimicrobial Proteins
- Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii
- (2017) Indu Khatri et al. Scientific Reports
- Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters
- (2016) Hon Wai Koon et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Prevalence of Small Intestinal Bacterial Overgrowth in Multiple Sclerosis: a Case-Control Study from China
- (2016) Yongbo Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Probiotics, gut microbiota, and their influence on host health and disease
- (2016) Borja Sánchez et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Functional anatomy of the colonic bioreactor: Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders
- (2016) Alexander Swidsinski et al. SYSTEMATIC AND APPLIED MICROBIOLOGY
- Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine
- (2016) Casey M. Theriot et al. mSphere
- Prevention ofClostridium difficileInfection withSaccharomyces boulardii: A Systematic Review
- (2016) Jennifer M Tung et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Systematic review with meta-analysis:Saccharomyces boulardiisupplementation and eradication ofHelicobacter pyloriinfection
- (2015) H. Szajewska et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis:Saccharomyces boulardiiin the prevention of antibiotic-associated diarrhoea
- (2015) H. Szajewska et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The role of the gut microbiome in the healthy adult status
- (2015) Valeria D’Argenio et al. CLINICA CHIMICA ACTA
- Saccharomyces boulardiiCNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea
- (2015) E.C. Dinleyici et al. Beneficial Microbes
- Saccharomyces boulardiiexpresses neuraminidase activity selective for α2,3-linked sialic acid that decreasesHelicobacter pyloriadhesion to host cells
- (2014) Serhan Sakarya et al. APMIS
- Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome
- (2014) Zaigham Abbas et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Mycobiota in gastrointestinal diseases
- (2014) Pranab K. Mukherjee et al. Nature Reviews Gastroenterology & Hepatology
- Chloride Secretion Induced by Rotavirus Is Oxidative Stress-Dependent and Inhibited by Saccharomyces boulardii in Human Enterocytes
- (2014) Vittoria Buccigrossi et al. PLoS One
- A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome
- (2011) Chang Hwan Choi et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut
- (2011) N J Mantis et al. Mucosal Immunology
- PROBIOTIC GASTROINTESTINAL ALLERGIC REACTION CAUSED BY SACCHAROMYCES BOULARDII
- (2010) Jin-Bok Hwang et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment
- (2010) A. Collignon et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Capric Acid Secreted by S. boulardii Inhibits C. albicans Filamentous Growth, Adhesion and Biofilm Formation
- (2010) Anna Murzyn et al. PLoS One
- Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii
- (2008) Marie-Claude Barc et al. ANAEROBE
- Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores
- (2008) J. A. Sorg et al. JOURNAL OF BACTERIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now